文献
J-GLOBAL ID:201802237137119912
整理番号:18A1206968
以前に治療された進行性非小細胞肺癌の日本人患者におけるアテゾリズマブ:第3相オーク試験のサブグループ分析【JST・京大機械翻訳】
Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study
著者 (10件):
Hida Toyoaki
(Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan)
,
Kaji Reiko
(Division of Integrated Oncology, Institute of Biomedical Research and Innovation Hospital, Kobe, Japan)
,
Satouchi Miyako
(Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Japan)
,
Ikeda Norihiko
(Department of Surgery, Tokyo Medical University, Tokyo, Japan)
,
Horiike Atsushi
(Department of Thoracic Medical Oncology, Japanese Foundation for Cancer Research Cancer Institute Hospital, Tokyo, Japan)
,
Nokihara Hiroshi
(Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Seto Takashi
(Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan)
,
Kawakami Tomohisa
(Chugai Pharmaceutical Co, Ltd, Tokyo, Japan)
,
Nakagawa Shintaro
(Chugai Pharmaceutical Co, Ltd, Tokyo, Japan)
,
Kubo Toshio
(Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan)
資料名:
Clinical Lung Cancer
(Clinical Lung Cancer)
巻:
19
号:
4
ページ:
e405-e415
発行年:
2018年
JST資料番号:
W3210A
ISSN:
1525-7304
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)